Understanding ARBs: Angiotensin Receptor Blockers for Blood Pressure & Heart Failure
ARBs (Angiotensin II Receptor Blockers) block the AT₁ receptor, preventing angiotensin II–mediated vasoconstriction, aldosterone release, sodium retention, and remodeling.
Common Agents
- Losartan (prototype), Valsartan, Irbesartan, Olmesartan, Telmisartan, Candesartan, Azilsartan.
Indications
- Hypertension (first-line, especially in diabetes/CKD).
- Heart failure with reduced EF (HFrEF) – alternative to ACEi.
- Post-MI LV dysfunction.
- Diabetic nephropathy (renoprotection).
- Stroke prevention (Losartan in LIFE trial).
Advantages over ACE Inhibitors
- No bradykinin accumulation → no cough (major tolerability advantage).
- Lower angioedema risk.
- Once-daily dosing (most).
Monitoring
- K⁺, Cr (baseline, 1–2 wks, periodically) – hyperkalemia, AKI risk.
- BP, volume status.
- Contraindicated in pregnancy (fetotoxicity).
ARBs are cornerstone RAAS blockade therapy with favorable side-effect profile.
Medical Billing - Related Articles
- Medical Billing Explained: A Comprehensive Guide for Healthcare Providers
- CPT Code 93306: Complete Transthoracic Echocardiogram with Doppler — Billing Guide
- Understanding Cooperative Housing Fees: What's Included?
- How to Pay Unpaid Hospital Bills: A Step-by-Step Guide
- Ace Your Coding Certification Exam: CPC & CCA-P Prep
- Understanding Medical Audit Procedures: Ensuring Quality & Compliance
- Understanding Deductibles: What Does 'Payment Applied' Mean?
